Warfarin initiation and monitoring with clotting factors II, VII, and X.
about
Heparin-induced thrombocytopenia: treatment options and special considerations.Binder phenotype: clinical and etiological heterogeneity of the so-called Binder maxillonasal dysplasia in prenatally diagnosed cases, and review of the literature.Effect of therapeutic plasma exchange on coagulation parameters in patients on warfarin.
P2860
Warfarin initiation and monitoring with clotting factors II, VII, and X.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Warfarin initiation and monitoring with clotting factors II, VII, and X.
@ast
Warfarin initiation and monitoring with clotting factors II, VII, and X.
@en
type
label
Warfarin initiation and monitoring with clotting factors II, VII, and X.
@ast
Warfarin initiation and monitoring with clotting factors II, VII, and X.
@en
prefLabel
Warfarin initiation and monitoring with clotting factors II, VII, and X.
@ast
Warfarin initiation and monitoring with clotting factors II, VII, and X.
@en
P2093
P2860
P356
P1476
Warfarin initiation and monitoring with clotting factors II, VII, and X.
@en
P2093
Ashley S Trask
Jaime A Diaz
Robert C Gosselin
William E Dager
P2860
P304
P356
10.1345/APH.1D266
P407
P577
2003-12-30T00:00:00Z